Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Fleseriu

Showing results (221-230 of 268) with videos related to

Pageof 27
Sort By:
Endocrine Journal|August 25, 2024
Osilodrostat treatment in patients with Cushing's disease of Asian or non-Asian origin: a pooled analysis of two Phase III randomized trials (LINC 3 and LINC 4)Akira Shimatsu, Beverly Mk Biller, Maria Fleseriu, et al.
European Journal of Endocrinology|October 17, 2022
Levoketoconazole treatment in endogenous Cushing's syndrome: extended evaluation of clinical, biochemical, and radiologic outcomesMaria Fleseriu, Richard J Auchus, Yona Greenman, et al.
Endocrine Connections|January 12, 2021
Risk factors and management of pasireotide-associated hyperglycemia in acromegalyMônica R Gadelha, Feng Gu, Marcello D Bronstein, et al.
Operative Neurosurgery (Hagerstown, Md.)|January 30, 2023
Defining the Clival Recess Surgical Corridor and Clival Classification System for Approach to Sellar PathologyNasser K Yaghi, David J Mazur-Hart, Erik W Larson, et al.
Pituitary|December 14, 2020
Correction to: Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing's syndromeEliza B Geer, Roberto Salvatori, Atanaska Elenkova, et al.
Pituitary|October 20, 2020
A Pituitary Society update to acromegaly management guidelinesMaria Fleseriu, Beverly M K Biller, Pamela U Freda, et al.
The Lancet. Diabetes & Endocrinology|February 1, 2024
A proposed clinical classification for pituitary neoplasms to guide therapy and prognosisKen K Y Ho, Maria Fleseriu, John Wass, et al.
Journal of Personalized Medicine|March 29, 2023
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin?Sabrina Chiloiro, Antonella Giampietro, Antonio Bianchi, et al.
Pituitary|November 20, 2020
Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing's syndromeEliza B Geer, Roberto Salvatori, Atanaska Elenkova, et al.
Journal of the Endocrine Society|January 19, 2026
A Novel Evaluation of 24-hour Energy Metabolism in Cushing's Syndrome: The Metabolic Cost of HypercortisolismAlessio Basolo, Isabella Lupi, Paolo Piaggi, et al.
Pageof 27

Showing results (221-230 of 268) with videos related to

Sort By:
Pageof 27
Endocrine Journal|August 25, 2024
Osilodrostat treatment in patients with Cushing's disease of Asian or non-Asian origin: a pooled analysis of two Phase III randomized trials (LINC 3 and LINC 4)Akira Shimatsu, Beverly Mk Biller, Maria Fleseriu, et al.
European Journal of Endocrinology|October 17, 2022
Levoketoconazole treatment in endogenous Cushing's syndrome: extended evaluation of clinical, biochemical, and radiologic outcomesMaria Fleseriu, Richard J Auchus, Yona Greenman, et al.
Endocrine Connections|January 12, 2021
Risk factors and management of pasireotide-associated hyperglycemia in acromegalyMônica R Gadelha, Feng Gu, Marcello D Bronstein, et al.
Operative Neurosurgery (Hagerstown, Md.)|January 30, 2023
Defining the Clival Recess Surgical Corridor and Clival Classification System for Approach to Sellar PathologyNasser K Yaghi, David J Mazur-Hart, Erik W Larson, et al.
Pituitary|December 14, 2020
Correction to: Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing's syndromeEliza B Geer, Roberto Salvatori, Atanaska Elenkova, et al.
Pituitary|October 20, 2020
A Pituitary Society update to acromegaly management guidelinesMaria Fleseriu, Beverly M K Biller, Pamela U Freda, et al.
The Lancet. Diabetes & Endocrinology|February 1, 2024
A proposed clinical classification for pituitary neoplasms to guide therapy and prognosisKen K Y Ho, Maria Fleseriu, John Wass, et al.
Journal of Personalized Medicine|March 29, 2023
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin?Sabrina Chiloiro, Antonella Giampietro, Antonio Bianchi, et al.
Pituitary|November 20, 2020
Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing's syndromeEliza B Geer, Roberto Salvatori, Atanaska Elenkova, et al.
Journal of the Endocrine Society|January 19, 2026
A Novel Evaluation of 24-hour Energy Metabolism in Cushing's Syndrome: The Metabolic Cost of HypercortisolismAlessio Basolo, Isabella Lupi, Paolo Piaggi, et al.
Pageof 27